Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Non-Muscle Invasive Bladder Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Melanoma 1Hematologic Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Colorectal Neoplasms 1Caregiver Burden 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Gemcitabine 15Mitomycin 10Docetaxel 7BCG Vaccine 7Cystoscopy 4tislelizumab 3durvalumab 3Radiotherapy 3Epirubicin 3disitamab vedotin 2avelumab 2Hyaluronic Acid 2tremelimumab 1toripalimab 1pemigatinib 1pembrolizumab 1monalizumab 1lornoxicam 1erdafitinib 1enzalutamide 1chondroitin sulfate, sodium hyaluronate drug combination 1bicalutamide 1Watchful Waiting 1VPM1002 recombinant BCG vaccine 1Urine Specimen Collection 1Ty21a typhoid vaccine 1Transurethral Resection of Bladder 1Therapeutics 1Surveys and Questionnaires 1Sugars 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Non-Muscle Invasive Bladder Neoplasms × Home Care Services × Clear all
NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Mayo Clinic

Phase 1/2 Recruiting
40 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡